NeuroPace, Inc. (NPCE) Cash Flow Statement
NeuroPace, Inc. (NPCE) generated -$11.2M of operating cash flow over the twelve months to 2026-06-30, spent $369000 on capital expenditure and had free cash flow of -$11.6M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NPCENeuroPace, Inc.Follow NPCE — free
—
Price chart with a free account
- Market cap
- 443.1M
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -24.6 | -36.9 | -19.7 | -17.9 | -11.0 | -11.2 | |
| Capital expenditure | 0.4 | 0.6 | 0.2 | 0.3 | 0.3 | -0.4 | |
| Free cash flow | -25.0 | -37.5 | -19.9 | -18.3 | -11.3 | -11.6 | |
| Dividends paid | 0.0 | 0.0 | 0.0 | — | — | — | |
| Share repurchases | — | — | — | 0.0 | 49.5 | — | |
| Stock-based compensation | 4.3 | 8.3 | 9.6 | 10.3 | 11.1 | — |
USD millions · SEC XBRL
NeuroPace, Inc. — questions
- What is NeuroPace, Inc.'s operating cash flow?
- -$11.2M over the twelve months to 2026-06-30.
- How much does NeuroPace, Inc. spend on capital expenditure?
- $369000 over the twelve months to 2026-06-30.
- What is NeuroPace, Inc.'s free cash flow?
- -$11.6M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from NeuroPace, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.